Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

DEA proposes restricting some telemedicine prescriptions

The proposed rules specifically narrow the prescribing of controlled substances via telemedicine for patients who have not been seen in person.

FDA authorizes first at-home flu and COVID-19 test

The test specifically can detect and differentiate between influenza A and B and the SARS-Cov-2 virus that causes COVID-19.

New ransomware threat with ties to Russia targets healthcare providers

The "prolific" ransomware group Clop is associated with Russia and has managed to breach some major healthcare systems.

Thumbnail

Regional One hit by data breach

Reventics, a revenue cycle management company and a business associate of Regional One Health, detected a cyber-intruder who accessed the company’s servers in December 2022.

CMS not changing ALZ drug restrictions

The announcement comes as more Alzheimer’s drugs are being evaluated with hopes that some new treatments could be breakthroughs.

Thumbnail

Cigna stops former executive from joining CVS Health

Cigna has blocked CVS Health from hiring Amy Bricker, a former Cigna executive, after a federal judge granted the company a temporary injunction.

 

More than 100 healthcare groups unite in support of prior authorization reform

The AMA and 118 other healthcare groups are urging CMS to finalize reforms that target prior authorization in Medicare Advantage plans that delay, deny and disrupt medically necessary care to patients.

Medicare money payment physician

More hospitals are complying with price transparency law

Even as progress is being made, some lawmakers want to increase penalties on hospitals that do not comply. 

Displaying 433 - 440 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup